triple glp 1 gip glucagon receptor agonist Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research Dual and Triple Gut Peptide
Description
doi: 10.1186/s40659-022-00404-3 123 ChanYHChaoTFChenSWLeeHFLiPRYehYHet al
The overall inflated cost adds to limitation of access to these drugs in resource poor nations (124)
doi: 10.1371/journal.pone.0158205
For additional details and discussion regarding pharmacologic approaches to glycemic management, please refer to the full 2020 ADA Standards of Medical Care
Try our personalized GLP-1 Plans
doi: 10.1523/JNEUROSCI.2212-10.2011
